Detalhe da pesquisa
1.
Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective analysis.
Breast Cancer Res Treat
; 194(3): 597-606, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35715538
2.
Birthweight and Chemotherapy Exposure in Women Diagnosed with Breast Cancer during Pregnancy.
Am J Perinatol
; 39(5): 554-561, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32971558
3.
Cancer control in Latin America and the Caribbean: recent advances and opportunities to move forward.
Lancet Oncol
; 22(11): e474-e487, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735817
4.
HER2-positive metastatic breast cancer: a comprehensive review.
Clin Adv Hematol Oncol
; 19(1): 40-50, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33493147
5.
Breast cancer-specific survival by age: Worse outcomes for the oldest patients.
Cancer
; 124(10): 2184-2191, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29499074
6.
De-escalating treatment in the adjuvant setting in HER2-positive breast cancer.
Future Oncol
; 14(10): 937-945, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29589471
7.
How we treat locally advanced HER2-positive breast cancer.
Clin Adv Hematol Oncol
; 17(5): 271-280, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31188804
8.
How Old is Too Old? Breast Cancer Treatment in Octogenarians.
Ann Surg Oncol
; 25(6): 1458-1460, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29633098
9.
Cost-effectiveness of ribociclib for premenopausal or perimenopausal women with HR+/HER2- advanced breast cancer: a Brazilian public health care system perspective.
Ther Adv Med Oncol
; 14: 17588359221100865, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36339925
10.
Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma.
Clin Cancer Res
; 27(20): 5688-5696, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34376532
11.
Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer.
Clin Cancer Res
; 26(22): 5974-5989, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32723837
12.
Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer.
Clin Cancer Res
; 26(11): 2565-2572, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32019858
13.
Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer.
Clin Cancer Res
; 26(11): 2556-2564, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32170028
14.
Evidence to date: talazoparib in the treatment of breast cancer.
Onco Targets Ther
; 12: 5177-5187, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31303769
15.
Response to Olaparib in a Patient with Germline BRCA2 Mutation and Breast Cancer Leptomeningeal Carcinomatosis.
NPJ Breast Cancer
; 5: 46, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31815182
16.
Cancer During Pregnancy: The Oncologist Overview.
World J Oncol
; 10(1): 28-34, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30834049
17.
Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials.
JCO Precis Oncol
; 32019.
Artigo
em Inglês
| MEDLINE | ID: mdl-32923853
18.
Primary ovary choriocarcinoma: individual DNA polymorphic analysis as a strategy to confirm diagnosis and treatment.
Rare Tumors
; 5(2): 89-92, 2013 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23888224